'Amaigrissement'
(id=156594686 ; fe=Amaigrissement ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=2064 creation date=2023-03-20 touchdate=2025-09-20 21:53:49.000) ≈ 381 relations sortantes
- Amaigrissement --
r_associated #0: 16 / 1 ->
perte de poids
n1=Amaigrissement | n2=perte de poids | rel=r_associated | relid=0 | w=16
- Amaigrissement --
r_associated #0: 11 / 0.688 ->
amaigrissant
n1=Amaigrissement | n2=amaigrissant | rel=r_associated | relid=0 | w=11
- Amaigrissement --
r_associated #0: 11 / 0.688 ->
balance
n1=Amaigrissement | n2=balance | rel=r_associated | relid=0 | w=11
- Amaigrissement --
r_associated #0: 11 / 0.688 ->
minceur
n1=Amaigrissement | n2=minceur | rel=r_associated | relid=0 | w=11
- Amaigrissement --
r_associated #0: 11 / 0.688 ->
obésité
n1=Amaigrissement | n2=obésité | rel=r_associated | relid=0 | w=11
- Amaigrissement --
r_associated #0: 11 / 0.688 ->
poids
n1=Amaigrissement | n2=poids | rel=r_associated | relid=0 | w=11
- Amaigrissement --
r_associated #0: 11 / 0.688 ->
régime
n1=Amaigrissement | n2=régime | rel=r_associated | relid=0 | w=11
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
abaissement
n1=Amaigrissement | n2=abaissement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
abrégement
n1=Amaigrissement | n2=abrégement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
abrègement
n1=Amaigrissement | n2=abrègement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
action de maigrir
n1=Amaigrissement | n2=action de maigrir | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
affinement
n1=Amaigrissement | n2=affinement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
altération de l'état général
n1=Amaigrissement | n2=altération de l'état général | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
Alzheimer (biomarqueurs de la maladie d')
n1=Amaigrissement | n2=Alzheimer (biomarqueurs de la maladie d') | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
Alzheimer (maladie d')
n1=Amaigrissement | n2=Alzheimer (maladie d') | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
alzheimérien
n1=Amaigrissement | n2=alzheimérien | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
alzheimérien (prise en charge d'un malade)
n1=Amaigrissement | n2=alzheimérien (prise en charge d'un malade) | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
amacrine
n1=Amaigrissement | n2=amacrine | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
amaigri
n1=Amaigrissement | n2=amaigri | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
amaigrir
n1=Amaigrissement | n2=amaigrir | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
amaigrissement excessif
n1=Amaigrissement | n2=amaigrissement excessif | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
amaigrissement pathologique
n1=Amaigrissement | n2=amaigrissement pathologique | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
amaigrissements
n1=Amaigrissement | n2=amaigrissements | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
amenuisement
n1=Amaigrissement | n2=amenuisement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
AMG
n1=Amaigrissement | n2=AMG | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
amincissement
n1=Amaigrissement | n2=amincissement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
amoindrissement
n1=Amaigrissement | n2=amoindrissement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
anorexie
n1=Amaigrissement | n2=anorexie | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
anorexie mentale
n1=Amaigrissement | n2=anorexie mentale | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
anorexique
n1=Amaigrissement | n2=anorexique | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
appauvrissement
n1=Amaigrissement | n2=appauvrissement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
asarcie
n1=Amaigrissement | n2=asarcie | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
atrophie
n1=Amaigrissement | n2=atrophie | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
atrophie généralisée
n1=Amaigrissement | n2=atrophie généralisée | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
cachexie
n1=Amaigrissement | n2=cachexie | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
cachexie maligne
n1=Amaigrissement | n2=cachexie maligne | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
charge
n1=Amaigrissement | n2=charge | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
cholangiocarcinome
n1=Amaigrissement | n2=cholangiocarcinome | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
clinique d'amaigrissement
n1=Amaigrissement | n2=clinique d'amaigrissement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
consomption
n1=Amaigrissement | n2=consomption | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
consomption
(amaigrissement)
n1=Amaigrissement | n2=consomption (amaigrissement) | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
corps thyroïde
n1=Amaigrissement | n2=corps thyroïde | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
cure
n1=Amaigrissement | n2=cure | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
cure d'amaigrissement
n1=Amaigrissement | n2=cure d'amaigrissement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
décroissance
n1=Amaigrissement | n2=décroissance | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
dégraissage
n1=Amaigrissement | n2=dégraissage | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
dépérissement
n1=Amaigrissement | n2=dépérissement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
dépréciation
n1=Amaigrissement | n2=dépréciation | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
dessèchement
n1=Amaigrissement | n2=dessèchement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
dévalorisation
n1=Amaigrissement | n2=dévalorisation | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
dévaluation
n1=Amaigrissement | n2=dévaluation | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
diminution
n1=Amaigrissement | n2=diminution | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
diminution du poids de
n1=Amaigrissement | n2=diminution du poids de | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
discale
n1=Amaigrissement | n2=discale | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
émaciation
n1=Amaigrissement | n2=émaciation | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
émaciations
n1=Amaigrissement | n2=émaciations | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
émacié
n1=Amaigrissement | n2=émacié | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
émaciement
n1=Amaigrissement | n2=émaciement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
émacier
n1=Amaigrissement | n2=émacier | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:5' 10' methylenetetrahydrofolate reductase deficiency
n1=Amaigrissement | n2=en:5' 10' methylenetetrahydrofolate reductase deficiency | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:abnormal metabolic state in diabetes mellitus
n1=Amaigrissement | n2=en:abnormal metabolic state in diabetes mellitus | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:abnormal weight loss (finding)
n1=Amaigrissement | n2=en:abnormal weight loss (finding) | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:acid-base imbalance
n1=Amaigrissement | n2=en:acid-base imbalance | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:acquired aminoacid metabolism disorder
n1=Amaigrissement | n2=en:acquired aminoacid metabolism disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:actual impaired nutritional status
n1=Amaigrissement | n2=en:actual impaired nutritional status | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:actual positive nutritional status
n1=Amaigrissement | n2=en:actual positive nutritional status | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:acute metabolic disorder
n1=Amaigrissement | n2=en:acute metabolic disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:alcohol intolerance
n1=Amaigrissement | n2=en:alcohol intolerance | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:alkalosis
n1=Amaigrissement | n2=en:alkalosis | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:alstrom syndrome
n1=Amaigrissement | n2=en:alstrom syndrome | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:amino acid metabolism disorder
n1=Amaigrissement | n2=en:amino acid metabolism disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:amyloidosis
n1=Amaigrissement | n2=en:amyloidosis | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:anisindione
n1=Amaigrissement | n2=en:anisindione | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:anisindione 50mg tablet
n1=Amaigrissement | n2=en:anisindione 50mg tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:anorexia
n1=Amaigrissement | n2=en:anorexia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:anorexia nervosa
n1=Amaigrissement | n2=en:anorexia nervosa | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:aspects of mortality statistics
n1=Amaigrissement | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:aspects of radionuclide imaging
n1=Amaigrissement | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:atrophia
n1=Amaigrissement | n2=en:atrophia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:atrophy
n1=Amaigrissement | n2=en:atrophy | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:avitaminosis
n1=Amaigrissement | n2=en:avitaminosis | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:azotemia
n1=Amaigrissement | n2=en:azotemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:boniness
n1=Amaigrissement | n2=en:boniness | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:bonyness
n1=Amaigrissement | n2=en:bonyness | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:brain diseases, metabolic
n1=Amaigrissement | n2=en:brain diseases, metabolic | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:cachexia
n1=Amaigrissement | n2=en:cachexia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:calcium metabolism disorders
n1=Amaigrissement | n2=en:calcium metabolism disorders | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:calcium/phosphate abnormality
n1=Amaigrissement | n2=en:calcium/phosphate abnormality | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:cancer cachexia
n1=Amaigrissement | n2=en:cancer cachexia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:carbohydrate metabolism disorder
n1=Amaigrissement | n2=en:carbohydrate metabolism disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:cardiac cachexia
n1=Amaigrissement | n2=en:cardiac cachexia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:caregiving to an alzheimerian patient
n1=Amaigrissement | n2=en:caregiving to an alzheimerian patient | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:carnosinemia
n1=Amaigrissement | n2=en:carnosinemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:chemically induced
n1=Amaigrissement | n2=en:chemically induced | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:cholangiocarcinoma
n1=Amaigrissement | n2=en:cholangiocarcinoma | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:chronic metabolic disorder
n1=Amaigrissement | n2=en:chronic metabolic disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:clinical manifestation of enzyme deficiency
n1=Amaigrissement | n2=en:clinical manifestation of enzyme deficiency | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:col1a1 associated connective tissue disorder
n1=Amaigrissement | n2=en:col1a1 associated connective tissue disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:combined oxidative phosphorylation deficiency 1
n1=Amaigrissement | n2=en:combined oxidative phosphorylation deficiency 1 | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:complication aspects
n1=Amaigrissement | n2=en:complication aspects | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:congenital mesh qualifier
n1=Amaigrissement | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:congenital metabolic disorder
n1=Amaigrissement | n2=en:congenital metabolic disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:constitutional syndrome
n1=Amaigrissement | n2=en:constitutional syndrome | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:cystic fibrosis
n1=Amaigrissement | n2=en:cystic fibrosis | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:depauperating
n1=Amaigrissement | n2=en:depauperating | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:diabetes mellitus
n1=Amaigrissement | n2=en:diabetes mellitus | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:diagnosis aspect
n1=Amaigrissement | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:dicumarol
n1=Amaigrissement | n2=en:dicumarol | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:dicumarol 25mg tablet
n1=Amaigrissement | n2=en:dicumarol 25mg tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:dicumarol 50 mg oral tablet
n1=Amaigrissement | n2=en:dicumarol 50 mg oral tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:dihydrouracil dehydrogenase deficiency
n1=Amaigrissement | n2=en:dihydrouracil dehydrogenase deficiency | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of acid-base balance
n1=Amaigrissement | n2=en:disorder of acid-base balance | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of aromatic amino acid metabolism
n1=Amaigrissement | n2=en:disorder of aromatic amino acid metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of beta alanine, carnosine and/or homocarnosine metabolism
n1=Amaigrissement | n2=en:disorder of beta alanine, carnosine and/or homocarnosine metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of blood gas
n1=Amaigrissement | n2=en:disorder of blood gas | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of fluid and/or electrolyte
n1=Amaigrissement | n2=en:disorder of fluid and/or electrolyte | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of glycoprotein metabolism
n1=Amaigrissement | n2=en:disorder of glycoprotein metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of glycosaminoglycan metabolism
n1=Amaigrissement | n2=en:disorder of glycosaminoglycan metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of iodine metabolism
n1=Amaigrissement | n2=en:disorder of iodine metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of ketone metabolism
n1=Amaigrissement | n2=en:disorder of ketone metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of lipoprotein and/or lipid metabolism
n1=Amaigrissement | n2=en:disorder of lipoprotein and/or lipid metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of mineral metabolism
n1=Amaigrissement | n2=en:disorder of mineral metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of neurometabolic regulation
n1=Amaigrissement | n2=en:disorder of neurometabolic regulation | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of osmoregulation
n1=Amaigrissement | n2=en:disorder of osmoregulation | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of protein metabolism
n1=Amaigrissement | n2=en:disorder of protein metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of pyrimidine metabolism
n1=Amaigrissement | n2=en:disorder of pyrimidine metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorder of steroid metabolism
n1=Amaigrissement | n2=en:disorder of steroid metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
n1=Amaigrissement | n2=en:disorders of branched-chain amino-acid metabolism and fatty-acid metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorders of lipoprotein metabolism and other lipidaemias
n1=Amaigrissement | n2=en:disorders of lipoprotein metabolism and other lipidaemias | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorders of porphyrin and bilirubin metabolism
n1=Amaigrissement | n2=en:disorders of porphyrin and bilirubin metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:disorders of sphingolipid metabolism and other lipid storage disorders
n1=Amaigrissement | n2=en:disorders of sphingolipid metabolism and other lipid storage disorders | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:dna repair-deficiency disorders
n1=Amaigrissement | n2=en:dna repair-deficiency disorders | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:dwindling
n1=Amaigrissement | n2=en:dwindling | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:eating disorder
n1=Amaigrissement | n2=en:eating disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:electrolyte depletion
n1=Amaigrissement | n2=en:electrolyte depletion | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:electrolyte disorder
n1=Amaigrissement | n2=en:electrolyte disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:electrolytes abnormal
n1=Amaigrissement | n2=en:electrolytes abnormal | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:emaciation
n1=Amaigrissement | n2=en:emaciation | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:embryologic
n1=Amaigrissement | n2=en:embryologic | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:endocrine and metabolic disturbances specific to the fetus and newborn
n1=Amaigrissement | n2=en:endocrine and metabolic disturbances specific to the fetus and newborn | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:endocrine and/or metabolic disorder specific to the fetus or newborn
n1=Amaigrissement | n2=en:endocrine and/or metabolic disorder specific to the fetus or newborn | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:endocrine, metabolic and nutritional
n1=Amaigrissement | n2=en:endocrine, metabolic and nutritional | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:enzyme abnormality (nos)
n1=Amaigrissement | n2=en:enzyme abnormality (nos) | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:enzymology
n1=Amaigrissement | n2=en:enzymology | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:enzymopathy
n1=Amaigrissement | n2=en:enzymopathy | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:epidemiologic
n1=Amaigrissement | n2=en:epidemiologic | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:ethanol metabolism disorder
n1=Amaigrissement | n2=en:ethanol metabolism disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:ethnologic
n1=Amaigrissement | n2=en:ethnologic | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:etiology aspects
n1=Amaigrissement | n2=en:etiology aspects | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:eunuchoid habitus
n1=Amaigrissement | n2=en:eunuchoid habitus | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:excessive weight loss
n1=Amaigrissement | n2=en:excessive weight loss | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:exposure as collected domain
n1=Amaigrissement | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:feebleness
n1=Amaigrissement | n2=en:feebleness | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:food issue
n1=Amaigrissement | n2=en:food issue | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:gauntness
n1=Amaigrissement | n2=en:gauntness | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:genetic aspects
n1=Amaigrissement | n2=en:genetic aspects | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:glandula thyroidea
n1=Amaigrissement | n2=en:glandula thyroidea | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:glucose metabolism abnormal
n1=Amaigrissement | n2=en:glucose metabolism abnormal | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:glucose metabolism disorder
n1=Amaigrissement | n2=en:glucose metabolism disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:gout
n1=Amaigrissement | n2=en:gout | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hemosiderosis
n1=Amaigrissement | n2=en:hemosiderosis | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hepatic encephalopathy
n1=Amaigrissement | n2=en:hepatic encephalopathy | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:historical aspects qualifier
n1=Amaigrissement | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hiv wasting syndrome
n1=Amaigrissement | n2=en:hiv wasting syndrome | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hyperbilirubinemia
n1=Amaigrissement | n2=en:hyperbilirubinemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hyperchloremia
n1=Amaigrissement | n2=en:hyperchloremia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hyperlactemia
n1=Amaigrissement | n2=en:hyperlactemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hyperlipidemia
n1=Amaigrissement | n2=en:hyperlipidemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hyperlipoproteinemia
n1=Amaigrissement | n2=en:hyperlipoproteinemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hyperlysinemia
n1=Amaigrissement | n2=en:hyperlysinemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hypermagnesemia
n1=Amaigrissement | n2=en:hypermagnesemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hypernatremia
n1=Amaigrissement | n2=en:hypernatremia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hyperpipecolatemia
n1=Amaigrissement | n2=en:hyperpipecolatemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hyperuricemia
n1=Amaigrissement | n2=en:hyperuricemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hypervolemia
n1=Amaigrissement | n2=en:hypervolemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hypoalphalipoproteinemia
n1=Amaigrissement | n2=en:hypoalphalipoproteinemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hypochloremia (disorder)
n1=Amaigrissement | n2=en:hypochloremia (disorder) | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hypomagnesemia
n1=Amaigrissement | n2=en:hypomagnesemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hyponatremia
n1=Amaigrissement | n2=en:hyponatremia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hypophosphatasia
n1=Amaigrissement | n2=en:hypophosphatasia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hypoproteinemia
n1=Amaigrissement | n2=en:hypoproteinemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:hypovolemia
n1=Amaigrissement | n2=en:hypovolemia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:immunology aspects
n1=Amaigrissement | n2=en:immunology aspects | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:impoverishing
n1=Amaigrissement | n2=en:impoverishing | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:in blood
n1=Amaigrissement | n2=en:in blood | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:in cerebrospinal fluid
n1=Amaigrissement | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:in urine
n1=Amaigrissement | n2=en:in urine | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:inanition
n1=Amaigrissement | n2=en:inanition | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:induced termination of pregnancy complicated by metabolic disorder
n1=Amaigrissement | n2=en:induced termination of pregnancy complicated by metabolic disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:intentional weight loss
n1=Amaigrissement | n2=en:intentional weight loss | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:iron metabolism disorders
n1=Amaigrissement | n2=en:iron metabolism disorders | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:issue with food
n1=Amaigrissement | n2=en:issue with food | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:kidney crystallization
n1=Amaigrissement | n2=en:kidney crystallization | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:lactose intolerance
n1=Amaigrissement | n2=en:lactose intolerance | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:langerhans cell histiocytosis
n1=Amaigrissement | n2=en:langerhans cell histiocytosis | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:lipid metabolism disorder
n1=Amaigrissement | n2=en:lipid metabolism disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:lipids abnormal
n1=Amaigrissement | n2=en:lipids abnormal | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:lipodystrophy
n1=Amaigrissement | n2=en:lipodystrophy | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:localized metabolic disorder
n1=Amaigrissement | n2=en:localized metabolic disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:lose weight
n1=Amaigrissement | n2=en:lose weight | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:losing weight
n1=Amaigrissement | n2=en:losing weight | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:loss of weight
n1=Amaigrissement | n2=en:loss of weight | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:lysosomal storage disease
n1=Amaigrissement | n2=en:lysosomal storage disease | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:maceration
n1=Amaigrissement | n2=en:maceration | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:macies
n1=Amaigrissement | n2=en:macies | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:malabsorption syndrome
n1=Amaigrissement | n2=en:malabsorption syndrome | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:malnutrition
n1=Amaigrissement | n2=en:malnutrition | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:medicine
n1=Amaigrissement | n2=en:medicine | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:metabolic acidosis
n1=Amaigrissement | n2=en:metabolic acidosis | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:metabolic and genetic disorder affecting the liver
n1=Amaigrissement | n2=en:metabolic and genetic disorder affecting the liver | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:metabolic aspects
n1=Amaigrissement | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:metabolic bone disorder
n1=Amaigrissement | n2=en:metabolic bone disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:metabolic disorder following molar and/or ectopic pregnancy
n1=Amaigrissement | n2=en:metabolic disorder following molar and/or ectopic pregnancy | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:metabolic disorder of fetus
n1=Amaigrissement | n2=en:metabolic disorder of fetus | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:metabolic disorder of transport
n1=Amaigrissement | n2=en:metabolic disorder of transport | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:metabolic disorders following abortion and ectopic and molar pregnancy
n1=Amaigrissement | n2=en:metabolic disorders following abortion and ectopic and molar pregnancy | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:metabolic renal disease
n1=Amaigrissement | n2=en:metabolic renal disease | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:metabolic syndrome
n1=Amaigrissement | n2=en:metabolic syndrome | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:metal metabolism disorder
n1=Amaigrissement | n2=en:metal metabolism disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:methionine adenosyltransferase deficiency
n1=Amaigrissement | n2=en:methionine adenosyltransferase deficiency | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:microbiological
n1=Amaigrissement | n2=en:microbiological | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:mitochondrial cytopathy
n1=Amaigrissement | n2=en:mitochondrial cytopathy | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:mitochondrial diseases
n1=Amaigrissement | n2=en:mitochondrial diseases | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:mitochondrial enzyme deficiency
n1=Amaigrissement | n2=en:mitochondrial enzyme deficiency | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:nickel metabolic disorder
n1=Amaigrissement | n2=en:nickel metabolic disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:nursing therapy
n1=Amaigrissement | n2=en:nursing therapy | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:nutritional and metabolic diseases
n1=Amaigrissement | n2=en:nutritional and metabolic diseases | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:nutritional and metabolic disorders in diseases classified elsewhere
n1=Amaigrissement | n2=en:nutritional and metabolic disorders in diseases classified elsewhere | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:nutritional disorder
n1=Amaigrissement | n2=en:nutritional disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:nutritional management
n1=Amaigrissement | n2=en:nutritional management | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:nutritional status
n1=Amaigrissement | n2=en:nutritional status | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:organic acid metabolism disorder
n1=Amaigrissement | n2=en:organic acid metabolism disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:other disorders of amino-acid metabolism
n1=Amaigrissement | n2=en:other disorders of amino-acid metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:other disorders of carbohydrate metabolism
n1=Amaigrissement | n2=en:other disorders of carbohydrate metabolism | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:other disorders of fluid, electrolyte and acid-base balance
n1=Amaigrissement | n2=en:other disorders of fluid, electrolyte and acid-base balance | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:other metabolic disorders
n1=Amaigrissement | n2=en:other metabolic disorders | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:other specified metabolic disorders
n1=Amaigrissement | n2=en:other specified metabolic disorders | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:other symptoms concerning nutrition, metabolism, and development
n1=Amaigrissement | n2=en:other symptoms concerning nutrition, metabolism, and development | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:other transitory neonatal endocrine and metabolic disturbances
n1=Amaigrissement | n2=en:other transitory neonatal endocrine and metabolic disturbances | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:pancreatic trypsinogen deficiency
n1=Amaigrissement | n2=en:pancreatic trypsinogen deficiency | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:parasitology
n1=Amaigrissement | n2=en:parasitology | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:pathological aspects
n1=Amaigrissement | n2=en:pathological aspects | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:pediatric failure to thrive
n1=Amaigrissement | n2=en:pediatric failure to thrive | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:pharmacotherapeutic
n1=Amaigrissement | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:phenprocoumon
n1=Amaigrissement | n2=en:phenprocoumon | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:phenprocoumon 3 mg oral tablet
n1=Amaigrissement | n2=en:phenprocoumon 3 mg oral tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:phosphorus metabolic disorder
n1=Amaigrissement | n2=en:phosphorus metabolic disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:physical examination procedures and organ system status
n1=Amaigrissement | n2=en:physical examination procedures and organ system status | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:physiopathological
n1=Amaigrissement | n2=en:physiopathological | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:polysyndactyly
n1=Amaigrissement | n2=en:polysyndactyly | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:polyuria
n1=Amaigrissement | n2=en:polyuria | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:porphyria
n1=Amaigrissement | n2=en:porphyria | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:postprocedural endocrine and metabolic disorders, not elsewhere classified
n1=Amaigrissement | n2=en:postprocedural endocrine and metabolic disorders, not elsewhere classified | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:potassium abnormality
n1=Amaigrissement | n2=en:potassium abnormality | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:protein energy malnutrition
n1=Amaigrissement | n2=en:protein energy malnutrition | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:proteinosis
n1=Amaigrissement | n2=en:proteinosis | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:proteostasis deficiencies
n1=Amaigrissement | n2=en:proteostasis deficiencies | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:pseudogout
n1=Amaigrissement | n2=en:pseudogout | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:psychology qualifier
n1=Amaigrissement | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:purine-pyrimidine metabolism, inborn errors
n1=Amaigrissement | n2=en:purine-pyrimidine metabolism, inborn errors | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:radiotherapeutic
n1=Amaigrissement | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:recent weight loss
n1=Amaigrissement | n2=en:recent weight loss | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:rehabilitation aspects
n1=Amaigrissement | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:renal secondary osteodystrophia fibrosa
n1=Amaigrissement | n2=en:renal secondary osteodystrophia fibrosa | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:roentgenographic
n1=Amaigrissement | n2=en:roentgenographic | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:rowley-rosenberg syndrome
n1=Amaigrissement | n2=en:rowley-rosenberg syndrome | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:salt-wasting syndrome of infancy
n1=Amaigrissement | n2=en:salt-wasting syndrome of infancy | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:siadh
n1=Amaigrissement | n2=en:siadh | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:sign
n1=Amaigrissement | n2=en:sign | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:skin diseases, metabolic
n1=Amaigrissement | n2=en:skin diseases, metabolic | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:slender build
n1=Amaigrissement | n2=en:slender build | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:slimming
n1=Amaigrissement | n2=en:slimming | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:slimming down
n1=Amaigrissement | n2=en:slimming down | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:small for gestational age
n1=Amaigrissement | n2=en:small for gestational age | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:sphingolipidosis
n1=Amaigrissement | n2=en:sphingolipidosis | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:surgical aspects
n1=Amaigrissement | n2=en:surgical aspects | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:symptoms concerning nutrition, metabolism, and development
n1=Amaigrissement | n2=en:symptoms concerning nutrition, metabolism, and development | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:synthetic defect of bile acids
n1=Amaigrissement | n2=en:synthetic defect of bile acids | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:tapering off
n1=Amaigrissement | n2=en:tapering off | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:taxonomic
n1=Amaigrissement | n2=en:taxonomic | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:therapeutic aspects
n1=Amaigrissement | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:thinness
n1=Amaigrissement | n2=en:thinness | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:thyroid
n1=Amaigrissement | n2=en:thyroid | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:thyroid body
n1=Amaigrissement | n2=en:thyroid body | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:thyroid gland
n1=Amaigrissement | n2=en:thyroid gland | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:tophus
n1=Amaigrissement | n2=en:tophus | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:tumor lysis syndrome
n1=Amaigrissement | n2=en:tumor lysis syndrome | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:unintentional weight loss
n1=Amaigrissement | n2=en:unintentional weight loss | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:unspecified endocrine and metabolic disturbances specific to the fetus and newborn
n1=Amaigrissement | n2=en:unspecified endocrine and metabolic disturbances specific to the fetus and newborn | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:uremia
n1=Amaigrissement | n2=en:uremia | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:use of ultrasonography
n1=Amaigrissement | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:veterinary aspects
n1=Amaigrissement | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:viruses
n1=Amaigrissement | n2=en:viruses | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin
n1=Amaigrissement | n2=en:warfarin | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin 2mg/ml powder for injection solution
n1=Amaigrissement | n2=en:warfarin 2mg/ml powder for injection solution | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin na 50mg/vil inj
n1=Amaigrissement | n2=en:warfarin na 50mg/vil inj | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin sodium
n1=Amaigrissement | n2=en:warfarin sodium | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin sodium 10mg tablet
n1=Amaigrissement | n2=en:warfarin sodium 10mg tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin sodium 1mg tablet
n1=Amaigrissement | n2=en:warfarin sodium 1mg tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin sodium 2.5mg tablet
n1=Amaigrissement | n2=en:warfarin sodium 2.5mg tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin sodium 2mg tablet
n1=Amaigrissement | n2=en:warfarin sodium 2mg tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin sodium 3mg tablet
n1=Amaigrissement | n2=en:warfarin sodium 3mg tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin sodium 4mg tablet
n1=Amaigrissement | n2=en:warfarin sodium 4mg tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin sodium 5 mg oral tablet
n1=Amaigrissement | n2=en:warfarin sodium 5 mg oral tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin sodium 6 mg oral tablet
n1=Amaigrissement | n2=en:warfarin sodium 6 mg oral tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin sodium 7.5 mg oral tablet
n1=Amaigrissement | n2=en:warfarin sodium 7.5 mg oral tablet | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:warfarin sodium isopropanol complex
n1=Amaigrissement | n2=en:warfarin sodium isopropanol complex | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:wasting
n1=Amaigrissement | n2=en:wasting | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:wasting syndrome
n1=Amaigrissement | n2=en:wasting syndrome | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:water intoxication
n1=Amaigrissement | n2=en:water intoxication | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:water-electrolyte imbalance
n1=Amaigrissement | n2=en:water-electrolyte imbalance | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:weight below normal
n1=Amaigrissement | n2=en:weight below normal | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:weight decreased
n1=Amaigrissement | n2=en:weight decreased | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:weight loss
n1=Amaigrissement | n2=en:weight loss | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:weight reduction
n1=Amaigrissement | n2=en:weight reduction | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
en:zinc deficiency disorder
n1=Amaigrissement | n2=en:zinc deficiency disorder | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
état amaigri
n1=Amaigrissement | n2=état amaigri | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
étésie
n1=Amaigrissement | n2=étésie | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
étisie
n1=Amaigrissement | n2=étisie | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
faire de
n1=Amaigrissement | n2=faire de | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
familier
n1=Amaigrissement | n2=familier | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
figuré
n1=Amaigrissement | n2=figuré | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
Folstein ( minimental test de)
n1=Amaigrissement | n2=Folstein ( minimental test de) | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
glande thyroïde
n1=Amaigrissement | n2=glande thyroïde | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
gras
n1=Amaigrissement | n2=gras | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
gros
n1=Amaigrissement | n2=gros | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
grossir
n1=Amaigrissement | n2=grossir | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
hectisie
n1=Amaigrissement | n2=hectisie | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
hypophagie
n1=Amaigrissement | n2=hypophagie | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
licenciement
n1=Amaigrissement | n2=licenciement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
littéraire
n1=Amaigrissement | n2=littéraire | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
maigre
n1=Amaigrissement | n2=maigre | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
maigreur
n1=Amaigrissement | n2=maigreur | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
maigrir
n1=Amaigrissement | n2=maigrir | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
malade
n1=Amaigrissement | n2=malade | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
maladie des chevaux
n1=Amaigrissement | n2=maladie des chevaux | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
marasme
n1=Amaigrissement | n2=marasme | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
marasme alimentaire
n1=Amaigrissement | n2=marasme alimentaire | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
marasme nutritionnel
n1=Amaigrissement | n2=marasme nutritionnel | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
médecine
n1=Amaigrissement | n2=médecine | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
menuiserie
n1=Amaigrissement | n2=menuiserie | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
Mini Mental State Examination (modèle d'interrogatoire)
n1=Amaigrissement | n2=Mini Mental State Examination (modèle d'interrogatoire) | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
ne pas grossir
n1=Amaigrissement | n2=ne pas grossir | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
oxymétholone
n1=Amaigrissement | n2=oxymétholone | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
pancréatite chronique calcifiante
n1=Amaigrissement | n2=pancréatite chronique calcifiante | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
pathologie
n1=Amaigrissement | n2=pathologie | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
perdre du poids
n1=Amaigrissement | n2=perdre du poids | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
perte
n1=Amaigrissement | n2=perte | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
perte de poids corporel
n1=Amaigrissement | n2=perte de poids corporel | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
perte pds
n1=Amaigrissement | n2=perte pds | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
perte pondérale
n1=Amaigrissement | n2=perte pondérale | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
pertes de poids
n1=Amaigrissement | n2=pertes de poids | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
poids abaissé
n1=Amaigrissement | n2=poids abaissé | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
poids diminué
n1=Amaigrissement | n2=poids diminué | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
prise
n1=Amaigrissement | n2=prise | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
processus pathologique
n1=Amaigrissement | n2=processus pathologique | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
réduction
n1=Amaigrissement | n2=réduction | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
régime
(alimentation)
n1=Amaigrissement | n2=régime (alimentation) | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
régime
(alimentation, restriction)
n1=Amaigrissement | n2=régime (alimentation, restriction) | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
retranchement
n1=Amaigrissement | n2=retranchement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
s'amaigrir
n1=Amaigrissement | n2=s'amaigrir | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
s'émacier
n1=Amaigrissement | n2=s'émacier | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
santé fragile
n1=Amaigrissement | n2=santé fragile | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
score d'Eckardt
n1=Amaigrissement | n2=score d'Eckardt | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
soustraction
n1=Amaigrissement | n2=soustraction | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
symptômes
n1=Amaigrissement | n2=symptômes | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
syndrome cachectique
n1=Amaigrissement | n2=syndrome cachectique | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
syndrome cachectique dû au vih
n1=Amaigrissement | n2=syndrome cachectique dû au vih | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
syndrome de cachexie
n1=Amaigrissement | n2=syndrome de cachexie | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
syndrome de cachexie progressive
n1=Amaigrissement | n2=syndrome de cachexie progressive | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
syndrome de dépérissement
n1=Amaigrissement | n2=syndrome de dépérissement | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
tabescence
n1=Amaigrissement | n2=tabescence | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
tabescence
(Nom)
n1=Amaigrissement | n2=tabescence (Nom) | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
thyréoïde
n1=Amaigrissement | n2=thyréoïde | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
thyroid
n1=Amaigrissement | n2=thyroid | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
thyroïde
n1=Amaigrissement | n2=thyroïde | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
thyroïdien
n1=Amaigrissement | n2=thyroïdien | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
trouble alimentaire
n1=Amaigrissement | n2=trouble alimentaire | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
trouble de l'alimentation
n1=Amaigrissement | n2=trouble de l'alimentation | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
trouble du comportement alimentaire
n1=Amaigrissement | n2=trouble du comportement alimentaire | rel=r_associated | relid=0 | w=10
- Amaigrissement --
r_associated #0: 10 / 0.625 ->
Weight Watchers
n1=Amaigrissement | n2=Weight Watchers | rel=r_associated | relid=0 | w=10
| ≈ 1 relations entrantes
- mastocytoses ---
r_associated #0: 22 -->
Amaigrissement
n1=mastocytoses | n2=Amaigrissement | rel=r_associated | relid=0 | w=22
|